Cell Therapeutics (CTIC) Correcting After Downward Trend
Tweet
Share
E-mail
Get Alerts CTIC Hot Sheet
Join SI Premium – FREE
Cell Therapeutics (Nasdaq: CTIC) is on the rise from an opening price of $0.95. Volume levels are also unusually high, at about 43 million. Shares of Cell Therapeutic have slid about 25% over the last month, trading as high at $1.55 on Sept. 18th.
At mid-day, the shares are trading at $1.12, up 15.31%.
We haven't heard any news on the Cell Therapeutics, and a call to the company was not immediately returned.
At mid-day, the shares are trading at $1.12, up 15.31%.
We haven't heard any news on the Cell Therapeutics, and a call to the company was not immediately returned.
You May Also Be Interested In
Create E-mail Alert Related Categories
Insiders' Blog, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
